Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.8/10
Best for: knowing which pharmacy fills the vial — it names Apostrophe Pharmacy LLC
Hims's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
No insurance needed · Vetted by our editors
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something Hims has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
The figures published here are not comparable monthly cash prices for the medication — an insured copay, a per-vial rate, a membership fee or a starting-dose teaser. Capped rather than scored against the register.
Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
On the seller's own pages, a price is published before the questionnaire starts.
1 FDA warning letter on record; names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is high.
Publishes coverage in 50 of 50 states.
The price covers medication.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Prices re-verified
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Check the price yourself before you pay
Every figure here was read off Hims's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Each partner below is a 503A or 503B pharmacy that Hims routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
“Apostrophe Pharmacy LLC is an additional dedicated licensed mail order pharmacy located in Arizona that provides prescription fulfillment services solely to Hims & Hers customers.”
Source: support.hims.com · Verified 2026-05-23
“XeCare, LLC is a dedicated licensed mail order pharmacy that provides prescription fulfillment services solely to Hims & Hers customers.”
Source: support.hims.com · Verified 2026-05-23
“Hims' Service provides access to prescription fulfillment services offered by ... Strive Specialties, Inc. and its affiliates.”
Source: www.hims.com · Verified 2026-05-23
“Hims' Service provides access to prescription fulfillment services offered by ... CD Pharmacy LLC ... d/b/a Red Rock Pharmacy.”
Source: www.hims.com · Verified 2026-05-23
Hims lists $199/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Check what is bundled before accepting it.
Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.
Hims prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The distinction is not cosmetic — the approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not.
On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. FDA has sent this operator a warning letter, and we flag it at the top of the page. A letter is a disclosure, not a disqualification: read what it actually says before deciding what it means for you. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Hims costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Breeze Meds is the nearest comparison we track, and worth reading alongside this. Whatever you decide, read the warning letter flagged at the top of this page first, and raise it with the clinician you would be prescribing through.
The Bottom Line
Hims's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Starting at $199/month. Check today's price, then book the free consultation.
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
The words sellers use, defined. Tap any term.
Regulatory notice
This letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Cited across this Hims review: primary regulatory filings, and peer-reviewed studies.
Plans start at $199/month. The free consultation is where you learn whether you qualify, and what it costs today.